Philip J O'Connell1, Weijia Zhang2, Madhav C Menon2, Zhengzi Yi2, Bernd Schröppel2, Lorenzo Gallon3, Yi Luan2, Ivy A Rosales4, Yongchao Ge5, Bojan Losic6, Caixia Xi2, Christopher Woytovich2, Karen L Keung2, Chengguo Wei2, Ilana Greene2, Jessica Overbey7, Emilia Bagiella7, Nader Najafian8, Milagros Samaniego9, Arjang Djamali10, Stephen I Alexander11, Brian J Nankivell1, Jeremy R Chapman1, Rex Neal Smith4, Robert Colvin4, Barbara Murphy12. 1. Renal Unit, University of Sydney at Westmead Hospital, Sydney, NSW, Australia. 2. Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 3. Department of Medicine-Nephrology and Surgery-Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 4. Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 5. Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 6. Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 7. Department of Health Evidence and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 8. Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. 9. Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA. 10. Division of Nephrology, Department of Medicine, University of Wisconsin, Madison, WI, USA. 11. Discipline of Child & Adolescent Health, The Children's Hospital at Westmead Clinical School, The University of Sydney, NSW, Australia. 12. Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: barbara.murphy@mountsinai.org.
Abstract
BACKGROUND: Chronic injury in kidney transplants remains a major cause of allograft loss. The aim of this study was to identify a gene set capable of predicting renal allografts at risk of progressive injury due to fibrosis. METHODS: This Genomics of Chronic Allograft Rejection (GoCAR) study is a prospective, multicentre study. We prospectively collected biopsies from renal allograft recipients (n=204) with stable renal function 3 months after transplantation. We used microarray analysis to investigate gene expression in 159 of these tissue samples. We aimed to identify genes that correlated with the Chronic Allograft Damage Index (CADI) score at 12 months, but not fibrosis at the time of the biopsy. We applied a penalised regression model in combination with permutation-based approach to derive an optimal gene set to predict allograft fibrosis. The GoCAR study is registered with ClinicalTrials.gov, number NCT00611702. FINDINGS: We identified a set of 13 genes that was independently predictive for the development of fibrosis at 1 year (ie, CADI-12 ≥2). The gene set had high predictive capacity (area under the curve [AUC] 0·967), which was superior to that of baseline clinical variables (AUC 0·706) and clinical and pathological variables (AUC 0·806). Furthermore routine pathological variables were unable to identify which histologically normal allografts would progress to fibrosis (AUC 0·754), whereas the predictive gene set accurately discriminated between transplants at high and low risk of progression (AUC 0·916). The 13 genes also accurately predicted early allograft loss (AUC 0·842 at 2 years and 0·844 at 3 years). We validated the predictive value of this gene set in an independent cohort from the GoCAR study (n=45, AUC 0·866) and two independent, publically available expression datasets (n=282, AUC 0·831 and n=24, AUC 0·972). INTERPRETATION: Our results suggest that this set of 13 genes could be used to identify kidney transplant recipients at risk of allograft loss before the development of irreversible damage, thus allowing therapy to be modified to prevent progression to fibrosis. FUNDING: National Institutes of Health.
BACKGROUND:Chronic injury in kidney transplants remains a major cause of allograft loss. The aim of this study was to identify a gene set capable of predicting renal allografts at risk of progressive injury due to fibrosis. METHODS: This Genomics of Chronic Allograft Rejection (GoCAR) study is a prospective, multicentre study. We prospectively collected biopsies from renal allograft recipients (n=204) with stable renal function 3 months after transplantation. We used microarray analysis to investigate gene expression in 159 of these tissue samples. We aimed to identify genes that correlated with the Chronic Allograft Damage Index (CADI) score at 12 months, but not fibrosis at the time of the biopsy. We applied a penalised regression model in combination with permutation-based approach to derive an optimal gene set to predict allograft fibrosis. The GoCAR study is registered with ClinicalTrials.gov, number NCT00611702. FINDINGS: We identified a set of 13 genes that was independently predictive for the development of fibrosis at 1 year (ie, CADI-12 ≥2). The gene set had high predictive capacity (area under the curve [AUC] 0·967), which was superior to that of baseline clinical variables (AUC 0·706) and clinical and pathological variables (AUC 0·806). Furthermore routine pathological variables were unable to identify which histologically normal allografts would progress to fibrosis (AUC 0·754), whereas the predictive gene set accurately discriminated between transplants at high and low risk of progression (AUC 0·916). The 13 genes also accurately predicted early allograft loss (AUC 0·842 at 2 years and 0·844 at 3 years). We validated the predictive value of this gene set in an independent cohort from the GoCAR study (n=45, AUC 0·866) and two independent, publically available expression datasets (n=282, AUC 0·831 and n=24, AUC 0·972). INTERPRETATION: Our results suggest that this set of 13 genes could be used to identify kidney transplant recipients at risk of allograft loss before the development of irreversible damage, thus allowing therapy to be modified to prevent progression to fibrosis. FUNDING: National Institutes of Health.
Authors: Serdar Yilmaz; Steven Tomlanovich; Timothy Mathew; Eero Taskinen; Timo Paavonen; Merci Navarro; Eleanor Ramos; Leon Hooftman; Pekka Häyry Journal: J Am Soc Nephrol Date: 2003-03 Impact factor: 10.121
Authors: A J Matas; J M Smith; M A Skeans; B Thompson; S K Gustafson; D E Stewart; W S Cherikh; J L Wainright; G Boyle; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2015-01 Impact factor: 8.086
Authors: Fernando G Cosio; Joseph P Grande; Hani Wadei; Timothy S Larson; Matthew D Griffin; Mark D Stegall Journal: Am J Transplant Date: 2005-10 Impact factor: 8.086
Authors: Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman Journal: N Engl J Med Date: 2003-12-11 Impact factor: 91.245
Authors: Shuang Wang; Jifu Jiang; Qiunong Guan; Hao Wang; Christopher Y C Nguan; Anthony M Jevnikar; Caigan Du Journal: Am J Physiol Renal Physiol Date: 2008-07-09
Authors: Geovani Faddoul; Girish N Nadkarni; Nancy D Bridges; Jens Goebel; Donald E Hricik; Richard Formica; Madhav C Menon; Yvonne Morrison; Barbara Murphy; Kenneth Newell; Peter Nickerson; Emilio D Poggio; David Rush; Peter S Heeger Journal: Transplantation Date: 2018-04 Impact factor: 4.939
Authors: Zhengzi Yi; Karen L Keung; Li Li; Min Hu; Bo Lu; Leigh Nicholson; Elvira Jimenez-Vera; Madhav C Menon; Chengguo Wei; Stephen Alexander; Barbara Murphy; Philip J O'Connell; Weijia Zhang Journal: JCI Insight Date: 2020-08-06